The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(Cyclohex-1-en-1-yl)-8-[5-(difluoromethyl)pyridin-3-yl][1,2,4]triazolo[4,3-a]quinoxaline ID: ALA4875626
PubChem CID: 164626798
Max Phase: Preclinical
Molecular Formula: C21H17F2N5
Molecular Weight: 377.40
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: FC(F)c1cncc(-c2ccc3ncc4nnc(C5=CCCCC5)n4c3c2)c1
Standard InChI: InChI=1S/C21H17F2N5/c22-20(23)16-8-15(10-24-11-16)14-6-7-17-18(9-14)28-19(12-25-17)26-27-21(28)13-4-2-1-3-5-13/h4,6-12,20H,1-3,5H2
Standard InChI Key: LQCFRUUPBAMHIY-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 32 0 0 0 0 0 0 0 0999 V2000
34.4155 -19.6910 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4144 -20.5146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1266 -20.9277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1248 -19.2821 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8375 -19.6874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8383 -20.5105 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5510 -20.9217 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.2633 -20.5068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5454 -19.2771 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.2576 -19.6776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.8572 -19.1238 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.5198 -18.3836 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.7075 -18.4759 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1511 -17.8723 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.4030 -17.0885 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8505 -16.4832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.0474 -16.6562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.7996 -17.4401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3509 -18.0510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7057 -19.2827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7068 -18.4603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9957 -18.0478 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2871 -18.4608 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2900 -19.2863 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.9975 -19.6910 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9949 -17.2306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7022 -16.8213 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
32.2868 -16.8227 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 10 1 0
9 5 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 9 1 0
14 15 1 0
14 19 2 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
13 14 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
1 20 1 0
22 26 1 0
26 27 1 0
26 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 377.40Molecular Weight (Monoisotopic): 377.1452AlogP: 5.23#Rotatable Bonds: 3Polar Surface Area: 55.97Molecular Species: NEUTRALHBA: 5HBD: ┄#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 4.01CX LogP: 3.03CX LogD: 3.03Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.49Np Likeness Score: -1.21
References 1. Berger M, Wortmann L, Buchgraber P, Lücking U, Zitzmann-Kolbe S, Wengner AM, Bader B, Bömer U, Briem H, Eis K, Rehwinkel H, Bartels F, Moosmayer D, Eberspächer U, Lienau P, Hammer S, Schatz CA, Wang Q, Wang Q, Mumberg D, Nising CF, Siemeister G.. (2021) BAY-8400: A Novel Potent and Selective DNA-PK Inhibitor which Shows Synergistic Efficacy in Combination with Targeted Alpha Therapies., 64 (17.0): [PMID:34428039 ] [10.1021/acs.jmedchem.1c00762 ]